Connection

Michael Lilly to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Follow-Up Studies.
Michael Lilly
Connection Strength
0.028
Follow-Up Studies
  1. Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. Cancer Treat Res Commun. 2020; 24:100193.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.